Everest Medicines CFO to join Morgan Stanley Biotech Without Borders fireside chatPUBT·Jul 27 at 10:15 AMMS+0.38%01952+1.13%
Hong Kong Market Shuffle: Tencent's AI Push and High-Yield Plays to Watch This WeekGlobal Report·Jul 25 at 04:13 AM02386-1.11%02635+7.19%
Everest Medicines Grants New Options and Share Awards Under 2026 SchemeTip Ranks·Jul 17 at 09:39 AM01952+1.13%
Everest Medicines grants 1,398,527 share awards under 2026 share schemePUBT·Jul 17 at 09:08 AM01952+1.13%
Inside Everest Medicines' USD 1 Billion Deal—and Sunmi's Satellite IoT PushGlobal Report·Jul 14 at 06:47 AM01952+1.13%06810-1.12%
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for CivorebrutinibAsian Corporate Newswire·Jul 7 at 11:57 PM01952+1.13%TVTX-1.63%
Everest Medicines Closes High-Value BTK Inhibitor Deal With TravereTip Ranks·Jul 7 at 04:37 AM01952+1.13%TVTX-1.63%
Vikail Pharma’s vicagrel antithrombotic drug wins China filing acceptance for market approvalPUBT·Jun 29 at 11:22 PM01952+1.13%
Everest Medicines shareholders adopt 2025 audited financial statements at AGMPUBT·Jun 26 at 04:11 AM01952+1.13%
Everest Medicines Announces China NMPA Acceptance of the Biologics License Application for LEROCHOL® in Adults with HypercholesterolemiaPR Newswire·Jun 25 at 09:08 PM01952+1.13%
ZheShang Venture-backed Maike Pharma jumps 86.92% in Hong Kong debut after HKD 1.06 billion IPOPUBT·Jun 24 at 02:59 AM02335+4.08%
